1 | Busulfan, Cyclophosphamide, Antithymocyte Globulin | 2件: Busulfan Busulfan, Cyclophosphamide | 3件: D00248
D00248
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 19 19, 20 |
2 | Busulfan, Cyclophosphamide, ATG | 2件: Busulfan Busulfan, Cyclophosphamide | 3件: D00248
D00248
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 19 19 |
3 | Busulfan, Cyclophosphamide, ATG, GCSF | 2件: Busulfan Busulfan, Cyclophosphamide | 3件: D00248
D00248
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 65 65, 284 |
4 | Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen) | 4件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Busulfan, Cyclophosphamide, Fludarabine | 4件: D00248
D00248
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 326 326 |
5 | Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine. | 4件: Busulfan Busulfan, Cyclophosphamide, Cyclosporine, Fludarabine | 5件: D00184
D00184
,
D00248
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 6件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 | 39件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 60 60, 285 |
6 | Campath, Fludarabine, Cyclophosphamide | 2件: Cyclophosphamide Cyclophosphamide, Fludarabine | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 284 |
7 | Cyclophosphamid | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 66 66 |
8 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
9 | Cyclophosphamide (CY) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
10 | Cyclophosphamide (CY) (Plan 1) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 60 60, 285 |
11 | Cyclophosphamide (CY) (Plan 2) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 60 60, 285 |
12 | Cyclophosphamide (Cytoxan) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 65 65 |
13 | Cyclophosphamide (drug) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 13 13 |
14 | Cyclophosphamide + pred | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 283 283 |
15 | Cyclophosphamide 100mg | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
16 | Cyclophosphamide 150mg | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
17 | Cyclophosphamide 30 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 3件: 65 65, 285, 326 |
18 | Cyclophosphamide 40 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 3件: 65 65, 285, 326 |
19 | Cyclophosphamide 50mg | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
20 | Cyclophosphamide 50Mg Oral Tablet | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 162 162 |
21 | Cyclophosphamide and ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 13 13 |
22 | Cyclophosphamide and fludarabine | 2件: Cyclophosphamide Cyclophosphamide, Fludarabine | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 11 11, 13 |
23 | Cyclophosphamide and steroids | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 222 222 |
24 | Cyclophosphamide Dose Level 1 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 65 65, 284 |
25 | Cyclophosphamide Dose Level 2 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 65 65, 284 |
26 | Cyclophosphamide Dose Level 3 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 65 65, 284 |
27 | Cyclophosphamide Dose Level 4 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 2件: 65 65, 284 |
28 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | 3件: Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | 4件: D00142
D00142
,
D00238
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 |
29 | Cyclophosphamide Injection 1g | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 3件: 50 50, 51, 52 |
30 | CYCLOPHOSPHAMIDE MONOHYDRATE | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 4件: 13 13, 60, 96, 256 |
31 | Cyclophosphamide post transplant | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 65 65 |
32 | Cyclophosphamide(CTX) | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 224 224 |
33 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | 4件: Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone, Prednisone | 5件: D00238
D00238
,
D00287
(Name: Cyclophosphamide),
D00407
,
D00473
,
D07760
(Name: Cyclophosphamide) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 |
34 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: D00287
D00287
(Name: Cyclophosphamide),
D00292
,
D03150
,
D07760
(Name: Cyclophosphamide) | 2件: NR3C1 NR3C1, PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 |
35 | Cyclophosphamide, Bortezomib, dexamethasone | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: D00287
D00287
(Name: Cyclophosphamide),
D00292
,
D03150
,
D07760
(Name: Cyclophosphamide) | 2件: NR3C1 NR3C1, PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 |
36 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | 4件: Bortezomib Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone | 5件: D00287
D00287
(Name: Cyclophosphamide),
D00292
,
D03150
,
D07760
(Name: Cyclophosphamide),
D10777
| 3件: CD38 CD38, NR3C1, PSMB5 💬 | 16件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | 1件: 28 28 |
37 | Cyclophosphamide, fludarabine , thymoglobulin | 3件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 |
38 | Cyclophosphamide, Fludarabine, Rabbit ATG | 4件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine, Rabbit | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 |
39 | Cyclophosphamide, Fludarabine, Thymoglobulin | 3件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclophosphamide, Fludarabine | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 |
40 | Cyclophosphamide,Campath IH and TBI | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
41 | Cyclophosphamide,cyclosporine A | 2件: Cyclophosphamide Cyclophosphamide, Cyclosporine | 3件: D00184
D00184
,
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 |
42 | Cyclophosphamide-prednisone-azathioprine | 3件: Azathioprine Azathioprine, Cyclophosphamide, Prednisone | 4件: D00238
D00238
,
D00287
(Name: Cyclophosphamide),
D00473
,
D07760
(Name: Cyclophosphamide) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 |
43 | Cyclophosphamide/ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 13 13 |
44 | Cyclophosphamide/Glatiramer acetate | 3件: Acetate Acetate, Cyclophosphamide, Glatiramer | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 13 13 |
45 | Cyclophosphamide/Rituximab | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
(Name: Cyclophosphamide),
D02994
,
D07760
(Name: Cyclophosphamide) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
46 | Cyclophosphamidum | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 44 44 |
47 | Cyclophosphamidum 500 mg | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 44 44 |
48 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | 4件: Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate | 4件: D00142
D00142
,
D00287
(Name: Cyclophosphamide),
D03899
,
D07760
(Name: Cyclophosphamide) | 4件: DHFR DHFR, DHFR2, TOP2A, TOP2B 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | 1件: 65 65 |
49 | Fludarabine, Cyclophosphamide | 2件: Cyclophosphamide Cyclophosphamide, Fludarabine | 3件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide),
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 |
50 | Glucocorticoid combined with cyclophosphamide induction + maintenance | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 222 222 |
51 | Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide'' | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 60 60 |
52 | High-dose Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 96 96 |
53 | IV Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
(Name: Cyclophosphamide),
D07760
(Name: Cyclophosphamide) | - | - | 1件: 51 51 |
54 | Lenalidomide, Dexamethasone and Cyclophosphamide | 3件: Cyclophosphamide Cyclophosphamide, Dexamethasone, Lenalidomide | 4件: D00287
D00287
(Name: Cyclophosphamide),
D00292
,
D04687
,
D07760
(Name: Cyclophosphamide) | 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 |
55 | Prednisone and cyclophosphamide | 2件: Cyclophosphamide Cyclophosphamide, Prednisone | 3件: D00287
D00287
(Name: Cyclophosphamide),
D00473
,
D07760
(Name: Cyclophosphamide) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
56 | Prednisone plus cyclophosphamide | 2件: Cyclophosphamide Cyclophosphamide, Prednisone | 3件: D00287
D00287
(Name: Cyclophosphamide),
D00473
,
D07760
(Name: Cyclophosphamide) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
57 | Prednisone, cyclophosphamide | 2件: Cyclophosphamide Cyclophosphamide, Prednisone | 3件: D00287
D00287
(Name: Cyclophosphamide),
D00473
,
D07760
(Name: Cyclophosphamide) | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 40 40 |
58 | Prednisone, methylprednisolone,cyclophosphamides | 2件: Methylprednisolone Methylprednisolone, Prednisone | 2件: D00407
D00407
,
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 |
59 | Rituximab and Cyclophosphamide IV | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
(Name: Cyclophosphamide),
D02994
,
D07760
(Name: Cyclophosphamide) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 35 35 |
60 | Rituximab, Cyclophosphamide, and Corticosteroids | 2件: Cyclophosphamide Cyclophosphamide, Rituximab | 3件: D00287
D00287
(Name: Cyclophosphamide),
D02994
,
D07760
(Name: Cyclophosphamide) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
61 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: D00287
D00287
(Name: Cyclophosphamide),
D00292
,
D03150
,
D07760
(Name: Cyclophosphamide) | 2件: NR3C1 NR3C1, PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 |
62 | Thalidomide, cyclophosphamide and prednisone | 3件: Cyclophosphamide Cyclophosphamide, Prednisone, Thalidomide | 4件: D00287
D00287
(Name: Cyclophosphamide),
D00473
,
D00754
,
D07760
(Name: Cyclophosphamide) | 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 331 331 |